Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cause specific mortality in an Italian pool of asbestos workers cohorts.
Ferrante D, Angelini A, Barbiero F, Barbone F, Bauleo L, Binazzi A, Bovenzi M, Bruno C, Casotto V, Cernigliaro A, Ceppi M, Cervino D, Chellini E, Curti S, De Santis M, Fazzo L, Fedeli U, Fiorillo G, Franchi A, Gangemi M, Giangreco M, Rossi PG, Girardi P, Luberto F, Massari S, Mattioli S, Menegozzo S, Merlo DF, Michelozzi P, Migliore E, Miligi L, Oddone E, Pernetti R, Perticaroli P, Piro S, Addario SP, Romeo E, Roncaglia F, Silvestri S, Storchi C, Zona A, Magnani C, Marinaccio A. Ferrante D, et al. Among authors: ceppi m. Am J Ind Med. 2024 Jan;67(1):31-43. doi: 10.1002/ajim.23546. Epub 2023 Oct 19. Am J Ind Med. 2024. PMID: 37855384
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis.
Molinelli C, Jacobs F, Agostinetto E, Nader-Marta G, Ceppi M, Bruzzone M, Blondeaux E, Schettini F, Prat A, Viale G, Del Mastro L, Lambertini M, de Azambuja E. Molinelli C, et al. Among authors: ceppi m. ESMO Open. 2023 Aug;8(4):101592. doi: 10.1016/j.esmoop.2023.101592. Epub 2023 Jul 4. ESMO Open. 2023. PMID: 37413762 Free PMC article.
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
Arecco L, Bruzzone M, Bas R, Kim HJ, Di Meglio A, Bernstein-Molho R, Hilbers FS, Pogoda K, Carrasco E, Punie K, Bajpai J, Agostinetto E, Lopetegui-Lia N, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Curigliano G, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Couch FJ, Dieci MV, Matikas A, Rozenblit M, Aguilar-Y Méndez D, De Marchis L, Puglisi F, Fabi A, Graff SL, Witzel I, Rodriguez Hernandez A, Fontana A, Pesce R, Duchnowska R, Pais HL, Sini V, Sokolović E, de Azambuja E, Ceppi M, Blondeaux E, Lambertini M. Arecco L, et al. Among authors: ceppi m. Ann Oncol. 2024 Sep;35(9):792-804. doi: 10.1016/j.annonc.2024.06.009. Epub 2024 Jun 20. Ann Oncol. 2024. PMID: 38908482 Free article.
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis.
Boutros A, Tanda ET, Croce E, Catalano F, Ceppi M, Bruzzone M, Cecchi F, Arecco L, Fraguglia M, Pronzato P, Genova C, Del Mastro L, Lambertini M, Spagnolo F. Boutros A, et al. Among authors: ceppi m. Eur J Cancer. 2023 Jul;188:64-79. doi: 10.1016/j.ejca.2023.04.010. Epub 2023 Apr 24. Eur J Cancer. 2023. PMID: 37196485 Free article. Review.
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer.
Lambertini M, Ceppi M, Anderson RA, Cameron DA, Bruzzone M, Franzoi MA, Massarotti C, El-Abed S, Wang Y, Lecocq C, Nuciforo P, Rolyance R, Pusztai L, Sohn J, Latocca MM, Arecco L, Pistilli B, Ruddy KJ, Ballestrero A, Del Mastro L, Peccatori FA, Partridge AH, Saura C, Untch M, Piccart M, Di Cosimo S, de Azambuja E, Demeestere I. Lambertini M, et al. Among authors: ceppi m. J Natl Compr Canc Netw. 2023 Jan;21(1):33-41.e16. doi: 10.6004/jnccn.2022.7065. J Natl Compr Canc Netw. 2023. PMID: 36634607
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
Debien V, Agostinetto E, Bruzzone M, Ceppi M, Martins-Branco D, Molinelli C, Jacobs F, Nader-Marta G, Lambertini M, de Azambuja E. Debien V, et al. Among authors: ceppi m. Clin Breast Cancer. 2024 Jul;24(5):421-430.e3. doi: 10.1016/j.clbc.2024.02.012. Epub 2024 Feb 21. Clin Breast Cancer. 2024. PMID: 38514306 Clinical Trial.
Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.
Kraxner A, Braun F, Cheng WY, Yang TO, Pipaliya S, Canamero M, Andersson E, Harring SV, Dziadek S, Bröske AE, Ceppi M, Tanos T, Teichgräber V, Charo J. Kraxner A, et al. Among authors: ceppi m. Front Immunol. 2024 Jul 5;15:1352632. doi: 10.3389/fimmu.2024.1352632. eCollection 2024. Front Immunol. 2024. PMID: 39035007 Free PMC article.
DNA damaging effects of occupational exposure to glass fibres. Response to Madl and Keeton paper.
Ceppi M, Smolkova B, Buocikova V, Rundén-Pran E, El Yamani N, Longhin EM, Murugadoss S, Staruchova M, Barancokova M, Volkovova K, Halašová E, Kyrtopoulos S, Bonassi S, Collins A, Dusinska M. Ceppi M, et al. Mutat Res Genet Toxicol Environ Mutagen. 2024 May-Jun;896:503770. doi: 10.1016/j.mrgentox.2024.503770. Epub 2024 May 22. Mutat Res Genet Toxicol Environ Mutagen. 2024. PMID: 38821672 No abstract available.
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study.
Curti S, Gallo M, Ferrante D, Bella F, Boschetti L, Casotto V, Ceppi M, Cervino D, Fazzo L, Fedeli U, Giorgi Rossi P, Giovannetti L, Girardi P, Lando C, Migliore E, Miligi L, Oddone E, Perlangeli V, Pernetti R, Piro S, Storchi C, Tumino R, Zona A, Zorzi M, Brandi G, Ferretti S, Magnani C, Marinaccio A, Mattioli S. Curti S, et al. Among authors: ceppi m. Med Lav. 2024 Apr 24;115(2):e2024016. doi: 10.23749/mdl.v115i2.14649. Med Lav. 2024. PMID: 38686579 Free PMC article.
226 results